Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;42(9):1999-2014.
doi: 10.1111/liv.15262. Epub 2022 Apr 2.

Incidence and risk factors of drug-induced liver injury

Xiaoyun Li  1 , Jieting Tang  1 , Yimin Mao  1
Affiliations
Review

Incidence and risk factors of drug-induced liver injury

Xiaoyun Li et al. Liver Int. 2022 Aug.

Abstract

The epidemiology and aetiology of drug-induced liver injury (DILI) vary across different countries and populations. Overall, DILI is rare in the general population but has become more prevalent in hospitalized patients, especially among patients with unexplained liver conditions. In addition, drugs implicated in DILI differ between Western and Eastern countries. Antibiotics are the leading drugs implicated in DILI in the West, whereas traditional Chinese medicine is the primary cause implicated in DILI in the East. The incidence of herbal and dietary supplements-induced hepatotoxicity is increasing globally. Several genetic and nongenetic risk factors associated with DILI have been described in the literature; however, there are no confirmed risk factors for all-cause DILI. Some factors may contribute to the risk of DILI in a drug-specific manner.

Keywords: drug-induced liver injury; epidemiology; hepatotoxicity; risk factor.

PubMed Disclaimer

References

    1. Hoofnagle JH, Björnsson ES. Drug-induced liver injury - types and phenotypes. N Engl J Med. 2019;381(3):264-273.
    1. Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58.
    1. Chen M, Zhang J, Wang Y, et al. The liver toxicity knowledge base: a systems approach to a complex end point. Clin Pharmacol Ther. 2013;93(5):409-412.
    1. Hoppmann NA, Gray ME, McGuire BM. Drug-induced liver injury in the setting of chronic liver disease. Clin Liver Dis. 2020;24(1):89-106.
    1. Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012;16(2):231-245.

Publication types

MeSH terms

LinkOut - more resources